Apolipoprotein B: An essential cholesterol metric for atherosclerotic cardiovascular disease
- 5 October 2022
- journal article
- editorial
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 80 (2), 83-86
- https://doi.org/10.1093/ajhp/zxac287
Abstract
In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.Keywords
This publication has 27 references indexed in Scilit:
- Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery CalcificationJournal of Invasive Cardiology, 2016
- Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-CEuropean Journal of Preventive Cardiology, 2015
- Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART studyAtherosclerosis, 2012
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular RiskCirculation: Cardiovascular Quality and Outcomes, 2011
- Using Apolipoprotein B to Manage Dyslipidemic Patients: Time for a Change?Mayo Clinic Proceedings, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein BArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugationAtherosclerosis, 1990
- Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].Proceedings of the National Academy of Sciences of the United States of America, 1980
- ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?The Lancet, 1979